Umar Nishan1, Wajid Ullah1, Nawshad Muhammad2, Muhammad Asad1, Saifullah Afridi1, Muslim Khan1, Mohibullah Shah3, Naeem Khan1, Abdur Rahim4. 1. Department of Chemistry, Kohat University of Science and Technology, Kohat, KP 26000, Pakistan. 2. Department of Dental Materials, Institute of Basic Medical Sciences Khyber Medical University, Peshawar, KP 25100, Pakistan. 3. Department of Biochemistry, Bahauddin Zakariya University, Multan 66000, Pakistan. 4. Interdisciplinary Research Centre in Biomedical Materials (IRCBM), COMSATS University Islamabad, Lahore Campus, Lahore 54000, Pakistan.
Abstract
Uric acid (UA) is a metabolic byproduct of purine nucleotides and is excreted as a urine component. Abnormalities in UA metabolism cause localized inflammation due to crystal deposition and can lead to various diseases. In the current study, we successfully fabricated a biosensor based on 1-H-3-methylimidazolium acetate (ionic liquid, IL)-capped nickel nanoparticles (NiNPs) for the detection of uric acid in test samples. The structures of IL-capped NiNPs and their precursors were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, and X-ray diffraction. The IL-capped NiNPs possessed intrinsic peroxidase-like properties and displayed selective UA quenching after interacting with 3,3',5,5'-tetramethylbenzidine (TMB) solution. Different parameters such as pH, time, IL, TMB, and UA concentration were optimized to obtain the best results for the proposed sensor. The UA biosensor shows good responses in the linear range from 1 × 10-8 to 2.40 × 10-6 M, with a lower limit of detection of 1.30 × 10-7 M, a limit of quantification of 4.3 × 10-7 M, and an R 2 value of 0.9994. For the colorimetric detection of UA, the proposed sensor gave a short time response of 4 min at room temperature and pH 7.5. The proposed sensing probe detects UA in real serum samples and could be used as a selective sensor for UA in the real sample detection.
Uric acid (UA) is a metabolic byproduct of purine nucleotides and is excreted as a urine component. Abnormalities in UA metabolism cause localized inflammation due to crystal deposition and can lead to various diseases. In the current study, we successfully fabricated a biosensor based on 1-H-3-methylimidazolium acetate (ionic liquid, IL)-capped nickel nanoparticles (NiNPs) for the detection of uric acid in test samples. The structures of IL-capped NiNPs and their precursors were characterized by Fourier transform infrared spectroscopy, scanning electron microscopy, and X-ray diffraction. The IL-capped NiNPs possessed intrinsic peroxidase-like properties and displayed selective UA quenching after interacting with 3,3',5,5'-tetramethylbenzidine (TMB) solution. Different parameters such as pH, time, IL, TMB, and UA concentration were optimized to obtain the best results for the proposed sensor. The UA biosensor shows good responses in the linear range from 1 × 10-8 to 2.40 × 10-6 M, with a lower limit of detection of 1.30 × 10-7 M, a limit of quantification of 4.3 × 10-7 M, and an R 2 value of 0.9994. For the colorimetric detection of UA, the proposed sensor gave a short time response of 4 min at room temperature and pH 7.5. The proposed sensing probe detects UA in real serum samples and could be used as a selective sensor for UA in the real sample detection.
In humans, uric acid (UA),
one of the most important metabolic
byproducts of purine nucleotides, is excreted in the urine.[1] Overproduction of UA, generated from purine metabolism
via xanthine oxidase, has been proven to play triggered roles in human
disease onset. A precise increase in the serum UA level is directly
associated with the disease severity and progression. At normal physiological
pH, UA acts as a weak acid (pKα 5.8) and exists as urate salt,
which upon excess deposition leads to UA crystal formation as monosodium
urate (MSU). The normal UA reference level in human blood is 2.5 to
7 mg/dL in men and 1.5 to 6 mg/dL in women.[1,2] The
normal physiological amount of UA in body fluids is balanced between
excretion and generation.[3] However, in
diseased conditions such as Lesch–Nyhan syndrome, hyperuricemia,
gout, and renal failure, UA has been proposed as a key diagnostic
marker.[4−6]Normally, UA concentration is measured in urine,
blood plasma,
and exhaled breath condensate. Determination of UA concentration has
been performed by uricase analysis,[7] chemiluminescence
(CL),[8] capillary electrophoresis (CE)[9,10] high-performance liquid chromatography (HPLC),[11] electrochemistry, dry chemistry systems, biosensor methods,
and so forth.[12] Generally, for the detection
of UA, chromatographic techniques such as CE and HPLC make great contributions
but require expensive instruments and complicated sample preparation
procedures. However, for the detection of UA in real samples with
a lower limit of detection and high accuracy, chemiluminescence and
electrochemistry-based analytical methods are still preferred.[13] Nevertheless, for the accurate determination
of UA, a simple, fast, and effective method is still required. As
a prerequisite of low cost, feasibility, and simplicity of no need
for sophisticated techniques, nonenzymatic chemosensor-based colorimetric
biosensor development has gained great attention.[14] Colorimetric detection of UA reported by Zhao et al.[7] has shown the development of intrinsic peroxidase-like
catalytic activity of BSA-stabilized Au nanoclusters. Although the
sensor shows high sensitivity, it possesses less specificity due to
its strong affinity toward Au and Ag nanoparticles.[15,16] Pal et al. reported a nonenzymatic platform for the colorimetric
detection of UA based on Ni@MnO2.[17] The results presented are encouraging, but in their work, Ni nanostructures
alone did not show any sensing activity. Tripathi et al. reported
that using Ni thin films deposited by glancing angle deposition (GLAD)
shows colorimetric sensing of UA in a nonenzymatic manner.[18] However, in their work, they showed that Ni
alone does not show any considerable sensing response toward UA sensing.Recently, our group has successfully shown the application of an
ionic liquid (IL) in enhancing the sensing properties of nanomaterial-based
sensing platforms for the detection of various analytes.[19,20] Owing to the emerging applications and versatile properties of ILs,
we hypothesized the functionalization of NiNPs with 1-H-3-methylimidazolium
acetate.In sensing applications, metal–organic frameworks
(MOFs)
have gained great attention. Due to their huge surface areas, stability,
variable architectures, exposed metal sites, and high and controllable
pore size, they represent a novel class of porous organic–inorganic
hybrid materials.[21] Although MOFs based
on colorimetric sensors have achieved some success, the development
of MOFs as enzyme mimics for bioanalysis applications is still required.
Although these MOFs show excellent lattice stability, a small pore
structure with a high density of active catalytic centers, and an
easy synthesis process.[22] These characteristics
of MOFs avoid the interference of other molecules in biological samples
and become suitable for catalytic applications. However, their colorimetric
detection application is still far from fully developed and is in
its infancy stage.[23]In this study,
nickel nanoparticles (NiNPs) were prepared by using
benzyl di-ethylene tri-amine as the stabilizing and reducing agent.
Characterization of the prepared NiNPs was carried out with standard
spectroscopic techniques, including X-ray diffraction (XRD), Fourier
transform infrared (FTIR) spectroscopy, and scanning electron microscopy
(SEM). After the synthesis and characterization, these NiNPs were
tuned with an IL as a colorimetric biosensor for UA detection. To
achieve the optimum performance of these IL-capped NiNPs, different
effecting parameters, such as pH, temperature, incubation period,
amount of Ni/IL, TMB, and UA concentrations were optimized. Finally,
for the qualitative and quantitative detection of UA, we developed
a simple and cost-effective biosensor method that can be observed
by naked eyes and UV–vis spectroscopy, respectively. Furthermore,
the proposed sensor was practically applied for the determination
of UA in real human serum samples.
Materials and Methods
Chemicals and Reagents
All the chemicals
and reagents used in this study were of analytical grade and were
acquired from Sigma Aldrich. These include nickel nitrate hexahydrate
(NiNO3.6H2O, 97%), uric acid (C5H4N4O3, 98%), 1-methylimidazole (C4H6N2), 3,3′,5,5′-tetramethylbenzidine
(TMB) sodium chloride (NaCl, 99%), acetic acid (CH3COOH,
97%), and sodium acetate (CH3COONa, 99%). Methanol and
ethanol (Sigma Aldrich) were used as solvents for washing purposes.
All the solutions were prepared in double-distilled water, and high-quality
Pyrex glass was used throughout the experiment.
Instrumentation
The distinctive peaks
of the prepared NiNPs were identified using an FTIR MX-300 system
(Agilent Technologies, Danbury, Conn, USA), and the desired functional
group spectrum within the range of 500–4000 cm–1 with 256 scans per sample at 4 cm–1 resolution
was recorded. A scanning electron microscope (JSM-5910, Japan) equipped
with an energy-dispersive X-ray (EDX) system was used for the size,
morphology, and elemental analyses of the prepared nanoparticles.
The crystal structure of the prepared nanoparticles was studied by
using an XRD-6100 system (Bruker Smart Apex CCD) equipped with monochromatic
Cu-Kα radiation (λ = 0.15418 nm). A quartz cuvette double
beam UV–vis spectrophotometer (Shimadzu, UV-1800, Germany)
was used for absorption spectra acquisition.
Preparation of Nickel Nanoparticles
To synthesize the desired NiNPs, a modified protocol was used as
reported recently by our group.[24] Briefly,
0.02 and 0.004 M solutions of nickel nitrate hexahydrate (NiNO3·6H2O) and benzyl di-ethylene tri-amine were
prepared in 50 mL double-distilled (dd) water, respectively. The 0.004
M solution of benzyl di-ethylene tri-amine was added dropwise to the
nickel nitrate solution and thoroughly stirred for about 60 min at
room temperature until the color of the mixture was changed from pale
blue to black. The synthesized NiNPs were pelleted out by centrifugation
at 4000 rpm for 10 min at 37 °C and oven-dried for 4 h at 50
°C after washing with ethanol twice. Finally, the synthesized
NiNPs were stored in 2 mL Eppendorf tubes at room temperature for
further use. The synthesis scheme of NiNPs is summarized in Figure A.
Figure 1
Schematic diagram for
the synthesis of the desired uric acid biosensor.
(A) Synthesis of NiNPs. (B) Synthesis of ILs. (C) Capping of NiNPs
with the ionic liquid.
Schematic diagram for
the synthesis of the desired uric acid biosensor.
(A) Synthesis of NiNPs. (B) Synthesis of ILs. (C) Capping of NiNPs
with the ionic liquid.
Synthesis of ILs
The synthesis of
IL was carried out as per our published protocol.[25] Briefly, 0.01 M acetic acid and 0.01 M 1-methylimidazole
were mixed with an equal ratio in two-neck flasks with constant stirring
for 6 h under cooling. A concentrated yellow color solution of IL
was obtained by a rotary evaporator and was stored at room temperature
for further use (Figure B.
Capping of NiNPs with ILs
A china
dish was used to soak roughly 6 mg of the produced NiNPs in 1 mL of
IL (1-H-3-methylimidazolium acetate) for capping. Maceration of the
IL-capped NiNPs was done for roughly 25 min with the use of a mortar
and pestle to produce the desired dispersion, as shown in Figure C. Furthermore, the
capping of the nanoparticles and IL was confirmed using FTIR analysis,
as shown in Figure B , Section .
Figure 2
(A) FTIR
spectrum of the prepared Ni nanoparticles. (B) Ionic liquid-capped
Ni nanoparticles.
(A) FTIR
spectrum of the prepared Ni nanoparticles. (B) Ionic liquid-capped
Ni nanoparticles.
Colorimetric Nonenzymatic Detection of Uric
Acid
Double-distilled water was used for the preparation
of all solutions used. Briefly, 40 μL of capped NiNPs was mixed
with TMB (0.08 M, 150 μL), H2O2 solution
(0.04 M, 90 μL), PBS (0.06 M, 550 μL), and UA (2.4 ×
10–6 M, 100 μL) and was incubated at ambient
temperature for 4 min. A greenish color appeared before UA addition,
which turned transparent after UA addition. The subsequent colorimetric
change was observed by naked eyes, further confirmed by UV–vis
spectrum (500–800 nm) analysis using a spectrophotometer.
Results and Discussion
FTIR Study of the Prepared Nickel Nanoparticles
The FTIR spectrum-based functional group analysis of the prepared
NiNPs is shown in Figure A. The key participating molecules involved in the synthesis
of NiNPs were investigated. The respective spectrum absorption bands
are displayed at 3444, 1640, 1466, 1370, and 1048 cm–1, as shown in Figure A. The presence of the amine group is indicated by the N–H
peaks at 3444 and 1640 cm–1, which were acquired
from benzyl di-ethylene tri-amine used in the reduction of NiNPs.
The 1466 cm–1 peak was assigned to the sp2 vibration of the C=H (alkene) bond. The existence of N–H
peaks suggested that the amine group is bound to the surface of NiNPs.
The C–H bending was observed at 1370 cm–1.[26] The IL-capped NiNP FTIR spectra have
been shown in Figure B. Along with new peaks, peak shifting was observed at 1466 and 1370
to 1260 and 1230 cm–1 of amine-coated NiNPs, which
confirms the capping of the ionic liquid 1-H-3-methylimidazolium acetate
with the Ni nanoparticles.
XRD Profile of the Synthesized Ni Nanoparticles
The XRD spectrum profile of the prepared NiNPs shows sharp peaks
at 20–80° that indicate its crystalline nature, as shown
in Figure . No impurity
peaks were found in the diffraction pattern, suggesting the ultrapure
phase of their synthesis. The presence of five sharp and prominent
diffraction peaks at 2θ values of 37.5°, 43.25°, 62.75°,
75.25°, and 80° corresponds to the crystal planes of (111),
(200), (220), (222), and (311), respectively, corresponding to JCPDS
Card No. 73-1523. The synthesized NiNP planes are face-centered cubic,
with a lattice constant of 4.17 Å, agreeing well with the standard
card data. Using the standard Debye-Scherrer equation, the average
crystal size was calculated to be 35 nm, as determined from the corresponding
X-ray spectral peak.[27,28]
Figure 3
XRD patterns of the synthesized NiNPs.
XRD patterns of the synthesized NiNPs.
SEM Analysis of the Prepared Ni Nanoparticles
To investigate the size and structure morphology of the prepared
NiNPs, SEM was used, as shown in Figure . The acquired SEM image shows irregular
NiNP agglomerates with void spaces. The microstructures are not very
clear, which have been confirmed by the Scherrer equation, as given
in Section 3.2. This agglomeration of NiNPs is due to the increase
in surface area-to-volume ratio that leads to an increase in attractive
forces among the particles to form spherical shapes.[29]
Figure 4
SEM images of the prepared NiNPs.
SEM images of the prepared NiNPs.
IL-Capped NiNP-Based Colorimetric Detection
of Uric Acid
The prepared NiNPs tuned with IL were used for
the colorimetric detection of uric acid, as shown in Figure . The desired detection analysis
was done by adding uric acid (2.4 μM,100 μL) after 4 min
of incubation to the colorimetric mixture having NiNPs (40 μL),
TMB (8 mM, 150 μL), H2O2 (4 mM,90 μL),
and PBS (6 mM,550 μL) solutions. The colorimetric change (greenish
to transparent) was observed by naked eyes, further confirmed by absorption
spectrum analysis (Figure ). The same colorimetric mixture composition without UA was
used as a normal control with a good absorption peak in the 550–700
nm range (Figure A).
No absorption peak was seen in the test sample having UA (Figure B).
Figure 5
IL-capped NiNP-based
colorimetric detection of uric acid. The absorption
spectra were recorded for the colorimetric mixture having TMB (8 mM,
150 μL), H2O2 (4 mM, 90 μL), and
PBS (6 mM, 550 μL) solutions with (2.4 μM, 100 μL)
(B) or without UA. (A) control.
IL-capped NiNP-based
colorimetric detection of uric acid. The absorption
spectra were recorded for the colorimetric mixture having TMB (8 mM,
150 μL), H2O2 (4 mM, 90 μL), and
PBS (6 mM, 550 μL) solutions with (2.4 μM, 100 μL)
(B) or without UA. (A) control.
Proposed Mechanism for IL-Capped NiNP-Based
Uric Acid Detection
The prepared IL-capped NiNPs act as a
biocatalyst by producing hydroxide radicals from H2O2 reduction that oxidize the TMB solution. In the presence
of uric acid, the oxidized TMB (blue-green) solution reverts to a
colorless reduced TMB product. Meanwhile, UA is converted into intermediate
Allontoin molecules that revert to UA in the presence of water molecules,
as shown in Scheme .
Scheme 1
Proposed Reaction Mechanism for IL-Capped NiNP-Based Uric Acid
Detection
Optimization of the Proposed Sensor
To investigate the potential biosensing role of the proposed IL-capped
NiNPs, different key parameters were optimized before being tested
in real blood samples. These are given below.
Optimization of IL-Capped NiNPs
As a key component of the proposed biosensor, different concentrations
of the ionic liquid-tuned NiNPs (10–70 μL) were tested
in a reaction mixture having the same composition as we mentioned
in Section 3.2. Briefly, 40 μL of IL-capped NiNPs was enough
to produce an optimum response. The reaction progress (blue-greenish
to transparent) can be noticed easily via naked eyes. Further confirmations
were done by absorption spectrum analysis by using a spectrophotometer,
as shown in Figure A.
Figure 6
IL-capped NiNP biosensor optimization. The key effecting parameters
were optimized to produce optimum results in the IL-capped NiNP biosensor
reaction mixture for UA detection. (A) Concentration–response
curves for IL-capped NiNP biosensor amounts (10–70 μL).
(B) Effect of the TMB solution concentration–response curve
(2–14 mM:150 μL) under optimized conditions. (C) Influence
of H2O2 solution concentrations (1–7
mM) on IL-capped NiNP biosensor, under optimized conditions. (D) Effect
of time variations (1–7 min) on IL-capped NiNP biosensor, under
optimized reaction mixture conditions. (E) Impact of pH variations
(1–13) on IL-capped NiNP biosensor, under optimized reaction
mixture conditions.
IL-capped NiNP biosensor optimization. The key effecting parameters
were optimized to produce optimum results in the IL-capped NiNP biosensor
reaction mixture for UA detection. (A) Concentration–response
curves for IL-capped NiNP biosensor amounts (10–70 μL).
(B) Effect of the TMB solution concentration–response curve
(2–14 mM:150 μL) under optimized conditions. (C) Influence
of H2O2 solution concentrations (1–7
mM) on IL-capped NiNP biosensor, under optimized conditions. (D) Effect
of time variations (1–7 min) on IL-capped NiNP biosensor, under
optimized reaction mixture conditions. (E) Impact of pH variations
(1–13) on IL-capped NiNP biosensor, under optimized reaction
mixture conditions.
Effect of TMB Concentration
As
the main colorimetric reporter component of the proposed biosensor,
different TMB concentrations (2–14 mM, 150 μL) were tested
in a reaction mixture having the same composition as we mentioned
in Section 3.2. Briefly, (8 mM, 150 μL) TMB solution was enough
to produce an optimum color response in the absence of UA. In the
presence of UA, the reaction progress (blue-greenish to transparent)
can be noticed easily via naked eyes. Further confirmation was done
by absorption spectrum analysis by using a spectrophotometer, as shown
in Figure B. Irrespective
of its previously reported 0.8 mM concentration,[30] in our current finding, the TMB solution shows the optimal
result at 8 mM concentration only. The main possible reason for these
1000× detection limit differences may be the nature, composition,
and oxidizing power of the different nanostructures.
Optimization of H2O2
H2O2 is the gold standard oxidizing
reagent for the reporter TMB solution. Therefore, optimal H2O2 concentration (4 mM, 90 μL) was determined by
using different H2O2 (1–7 mM) concentrations.
The proposed biosensors (IL-capped NiNPs) showed a maximum response
at this optimal (4 mM:90 μL) H2O2 concentration
in the reaction mixture, as shown in Figure E. Meanwhile, the reported H2O2 concentration (8 mM:500 μL) was not suitable for our
current (IL-capped NiNPs) biosensors.[31] The possible reasons may be its purity, sensitivity, reaction mixture
composition, their peroxidase-like activities, and so forth.
pH Effect on the Proposed Biosensor
In the physiological system, pH is one of the most influential factors
responsible for the onset of prohibition of a chemical reaction. The
desired biosensor (IL-capped NiNPs) was calibrated at different pH
modules (1–13) using hydrochloric acid (HCL) and sodium hydroxide
(NaOH) solutions. The optimal result for the IL-capped NiNP biosensor
was found at pH 7.5, as shown in Figure C. However, in a normal enzymatic scenario,
the reaction occurs at pH 4.[3]
Effect of Time on the Proposed Biosensor
Time is one of the most influential factors in numerous biochemical
reactions. Therefore, the desired biosensor (IL-capped NiNPs) was
optimized at different time intervals (0–8 min). The optimal
result was achieved after 4 min, irrespective of the previously reported
15 min intervals.[30] The desired time-based
response (colorimetric change) was noticed by visual observation and
confirmed by UV–vis spectrum analysis, as shown in Figure D.
Steady-State Kinetic Analysis
The
Michaelis–Menten equation was used to calculate the Michaelis
constant (Km) and maximum velocity (Vmax) for the proposed sensing
platform (IL-capped NiNPs). As can be seen in Table the proposed platform demonstrates a very
low Km value of 0.017 for TMB and 0.01 for H2O2. The lower value is desirable as it indicates that the IL-capped
NiNPs have a greater affinity for the substrates. Moreover, when compared
with the literature, the Vmax value of IL-capped NiNPs is higher,
as can be seen in Table . In comparsion to the values obtained for other catalysts, it is
clear that IL-capped NiNPs demonstrate good catalytic behavior for
the oxidation of TMB in the presence of H2O2.
Table 1
Comparsion of Kinetic Parameters of
IL-Capped NiNPs and HRP
catalysts
substrate
Vmax (10–8 M·s–1)
Km (mM)
ref
HRP
TMB
17.19
0.424
(32)
HRP
H2O2
10.55
3.240
IL-capped NiNPs
TMB
32
0.017
this work
IL-capped NiNPs
H2O2
45
0.01
Analytical Characteristics of the Proposed
IL-Capped NiNP Biosensor
For the colorimetric detection of
UA concentration, the key biosensing features of the proposed IL-capped
NiNP biosensor were studied using standard calibration curves, as
shown in Figure .
Under optimized conditions, the proposed colorimetric sensing probe
was tested in the uric acid concentration range of 1 × 10–8–2.4 × 10–6 M. It exhibited
peroxidase-like activity in a wide linear range. The uric acid concentration
in the reaction mixture was inversely proportional to the absorption
peak that can be noticed from the reduction of the UV–vis spectral
peak at 652, as shown in Figure . The proposed biosensor shows a good linear response
in the range of 1 × 10–8–2.4 ×
10–6 M, with an LOQ of 4.3 × 10–7 M, an LOD of 1.30 × 10–7 M, and an R2 value of 0.9994. These values were calculated
by using the formulas (10σ/slope) for LOQ and (3σ/slope)
for LOD. The slope value was derived from the linear curve, while
σ shows the blank sample standard deviation. The proposed IL-capped
NiNP biosensor shows a good limit of detection (LOD) of 1.3 μM
and an R2 value of 0.995 compared to that
of the literature-reported UA sensor.[3] Similarly,
the analytical efficiency of the proposed IL-capped NiNP biosensor
was good, as shown in Table compared with that of the already reported biosensors.[7,33−39]
Figure 7
IL-capped
NiNP-based UA biosensing. Different UA concentrations
(1 × 10–8–2.4 × 10–6 M) were mixed with an optimized reaction mixture. (A) Upper top
right shows colorimetric change with respect to different concentrations
of UA and the bottom graph represents the respective UV–vis
spectra. (B) Calibration plot of UA concentration versus absorbance.
Table 2
Comparative Analysis of the Proposed
IL-Capped NiNP Biosensor for Uric Acid Detection
s. no
materials used
linear range
(μΜ)
limit of detection
(μM)
ref
1
luminol–K3[Fe(CN)6]
4.8–179
3
(33)
2
uricase/AuNP/MWCNT Au electrode
10–800
10
(34)
3
TMB–Cu2+–uricase
1–100
640
(35)
4
CdTe nanoparticles
0.22–6
100
(36)
5
uricase/BSA-stabilized Au
nanoclusters
2.0–200
0.36
(7)
6
uricase/HRP–CdS quantum
dots
125–1000
125
(37)
7
nanocrystalline cobalt selenide
TMB
2.0–40
500
(39)
8
Ni GLAD film
15–500
3.3
(18)
9
Ni@MnO2
1–40
0.24
(17)
8
IL-capped NiNPs
0.01–2.40
0.13
this work
IL-capped
NiNP-based UA biosensing. Different UA concentrations
(1 × 10–8–2.4 × 10–6 M) were mixed with an optimized reaction mixture. (A) Upper top
right shows colorimetric change with respect to different concentrations
of UA and the bottom graph represents the respective UV–vis
spectra. (B) Calibration plot of UA concentration versus absorbance.
To investigate the potential UA detection selectivity
with the peculiar sensitivity of IL-capped NiNP biosensor, interference
profile studies were done. The absorbance response of the proposed
biosensor was measured in the presence of other coexisting species,
including ethanol, methanol, dopamine, urea, Ca+2, K+, ascorbic acid, glutathione, and UA, as shown in Figure . Except for UA,
none of the coexisting species were found to reduce the oxidized TMB
solution (greenish to transparent) in the presence of IL-capped NiNP
biosensor. Thus, the obtained results demonstrate high selectivity
and good sensitivity of IL-capped NiNP biosensors for UA detection.
The results indicate that the coexistence of these interfering substances
does not affect the detection of UA. Thus, the proposed biosensor
shows great potential to be tested for UA detection in real serum
samples.
Figure 8
IL-capped NiNP biosensor interference profiling. The interference
to the IL-capped NiNP biosensor by the coexisting species at 2.40
× 10–6 M concentrations including (A) ethanol,
(B) K+, (C) urea, (D) dopamine, (E) methanol, (F) Ca2+, (G) ascorbic acid, (H) glutathione, and(I) uric acid.
IL-capped NiNP biosensor interference profiling. The interference
to the IL-capped NiNP biosensor by the coexisting species at 2.40
× 10–6 M concentrations including (A) ethanol,
(B) K+, (C) urea, (D) dopamine, (E) methanol, (F) Ca2+, (G) ascorbic acid, (H) glutathione, and(I) uric acid.
Clinical Applications of IL-Capped NiNP Biosensors
The proposed IL-capped NiNP biosensor was tested in real serum
samples using the same experimental conditions, except for uric acid
addition. Instead of direct UA addition, human serum samples (100
μL) were added to the reaction mixtures. Different UA concentrations
of 0.295, 0.692, and 1.37 μM were spiked into the real serum
samples by using the standard UA calibration method, as shown in Figure . Thus, by using
different UA concentrations under the same optimized conditions, the
unknown serum UA concentration was calculated based on a previously
established calibration plot. The % recovery algorithm was used to
calculate the findings, as displayed in Table . Finally, the proposed IL-capped NiNPs biosensor
was tested for multiple serum samples’ UA detection. The proposed
biosensor was able to detect UA in serum samples with the highest
sensitivity and selectivity.
Figure 9
Real serum sample UA profile. IL-capped NiNP
biosensor-based UV–vis
spectra of the real blood serum samples at optimized reaction mixture
conditions having different UA concentrations. However, the concentration
of A is (3 × 10–7 M), B is (7 × 10–7 M), and C is (1.4 × 10–6 M).
Table 3
IL-Capped NiNP Biosensor-Based Detection
of Uric Acid in Human Serum Samples
samples
detected (μM)
uric acid added
(μM)
uric acid found
(μM)
recovery (%)
RSD (%)
1
0.005
0.295
0.3
101.69
0.838
2
0.008
0.692
0.7
101.15
1.009
3
0.03
1.37
1.4
102.18
0.459
Real serum sample UA profile. IL-capped NiNP
biosensor-based UV–vis
spectra of the real blood serum samples at optimized reaction mixture
conditions having different UA concentrations. However, the concentration
of A is (3 × 10–7 M), B is (7 × 10–7 M), and C is (1.4 × 10–6 M).
Conclusions
In the present study, we
synthesized IL-capped NiNPs as efficient
uric acid biosensors under normal physiological conditions. The proposed
biosensor was confirmed by using standard spectroscopic techniques.
Different parameters such as pH, time, TMB, and H2O2 solution were optimized. Under optimized conditions, the
sensing probe for uric acid detection was tested successfully in a
wide linear range, which gave a low limit of detection and low limit
of quantification. This newly explored IL-tuned NiNP biosensor shows
numerous advantages, including low cost, facile preparation, good
stability, and high catalytic efficiency with peculiar selectivity
in a minimal timeframe detection. The desired biosensor was able to
detect UA with the highest sensitivity and selectivity, irrespective
of the presence of coexisting molecules’ hindrances. Even more,
with the same sensitivity and selectivity, UA was determined in real
serum samples, suggesting their potential diagnostic role shortly.
Therefore, we predict that soon the proposed IL-capped NiNP biosensor
would be used for the selective detection of uric acid in multiple
diverse sample analyses.